Tuberculosis treatment: one-shot approach or cascade of regimens?

Lancet Respir Med. 2020 Feb;8(2):e4-e5. doi: 10.1016/S2213-2600(19)30473-4.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Diarylquinolines
  • Humans
  • Moxifloxacin
  • Nitroimidazoles
  • Pyrazinamide
  • Tuberculosis*
  • Tuberculosis, Pulmonary*

Substances

  • Diarylquinolines
  • Nitroimidazoles
  • pretomanid
  • Pyrazinamide
  • bedaquiline
  • Moxifloxacin